Acute and chronic pain: Where we are and where we have to go

Minerva Anestesiologica

Volumn 78, Issue 2, 2012, Pages 222-235

  Allegri, M ^a,b,g   Clark, M R ^c,g   de Andres J ^d,e,g   Jensen, T S ^f,g  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c DEPARTMENT OF PATHOLOGY   (United States)

^d UNIVERSITY OF VALENCIA   (Spain)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f AARHUS UNIVERSITY HOSPITAL   (Denmark)

^g Study In Multidisciplinary PAin Research (SIMPAR) Group   (Italy)

Author keywords

Anesthesia; Opioids; Pain; Pain, postoperative

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; CODEINE; LEVOBUPIVACAINE; LOCAL ANESTHETIC AGENT; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; NARCOTIC ANALGESIC AGENT; ROPIVACAINE; TRICYCLIC ANTIDEPRESSANT AGENT;

BLEEDING; CANCER PAIN; CHRONIC PAIN; CNA1B GENE; COMT GENE; DRUG ABSORPTION; DRUG ACCUMULATION; DRUG ACTIVATION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG CLEARANCE; DRUG DEPENDENCE; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ELIMINATION; DRUG INACTIVATION; DRUG METABOLISM; EPIDURAL ANESTHESIA; FAILED BACK SURGERY SYNDROME; FIBROMYALGIA; GENE; GENETIC POLYMORPHISM; HEREDITY; HUMAN; KCNQ2 GENE; LAPAROSCOPY; LOW BACK PAIN; MIGRAINE; NEBULIZATION; NECK PAIN; NERVE BLOCK; NEUROPATHIC PAIN; NEUROTOXICITY; NOCICEPTION; NONHUMAN; OPRM1 GENE; PAIN; PARALYSIS; PARESTHESIA; PATHOPHYSIOLOGY; PERSONALIZED MEDICINE; POSTOPERATIVE PAIN; REGIONAL ANESTHESIA; REVIEW; SCN9A GENE; SPINAL ANESTHESIA; SPINAL PAIN; UNSPECIFIED SIDE EFFECT;

ACUTE PAIN; BACK PAIN; CHRONIC PAIN; HUMANS; NEOPLASMS; PAIN, POSTOPERATIVE; TREATMENT FAILURE;

EID: 84856564614     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (147)

1. Langford DJ, Bailey AL, Chanda ML, Clarke SE, Drummond TE, Echols S et al. Coding of facial expressions of pain in the laboratory mouse. Nat Methods 2010;7:447-9.
2. Mogil JS, Davis KD, Derbyshire SW. The necessity of animal models in pain research. Pain 2010;151:12-7.
3. Basbaum AI, Bautista DM, Scherrer G, Julius D. Cellular and molecular mechanisms of pain. Cell 2009;139:267-84.
4. Langley PC. The prevalence, correlates and treatment of pain in the European Union. Curr Med Res Opin 2011;27:463-80.
5. Langley P, Müller-Schwefe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The societal impact of pain in the European Union: health-related quality of life and healthcare resource utilization. J Med Econ 2010;13:571-81.
6. Langley P, Müller-Schwefe G, Nicolaou A, Liedgens H, Pergolizzi J, Varrassi G. The impact of pain on labor force participation, absenteeism and presenteeism in the European Union. J Med Econ 2010;13:662-72.
7. Merskey H, Bogduk N. Part III: Pain terms-a current list with definitions and notes on usage. In: IASP Task Force on Taxonomy. Classification of chronic pain. 2nd ed. Seattle, WAS: IASP; 1994. p. 209-14
8. International Pain Summit Of The International Association For The Study Of Pain Declaration of Montréal: declaration that access to pain management is a fundamental human right. J Pain Palliat Care Pharmacother 2011;25:29-31.
9. Woolf CJ. What is this thing called pain? J Clin Invest 2010;120:3742-4.
10. Møller AT, Jensen TS. Pain and genes: genetic contribution to pain variability, chronic pain and analgesic responses. Eur J Pain Suppl 2010;4:197-201.
11. Lacroix-Fralish ML, Ledoux JB, Mogil JS. The Pain Genes Database. An interactive web browser of pain-related transgenic knockout studies. Pain 2007;131:1-4.
12. Gervil M, Ulrich V, Kyvik KO, Olesen J, Russell MB. Migraine without aura: a population-based twin study. Ann Neurol 1999;46:606-11.
13. Hartvigsen J, Nielsen J, Kyvik KO, Fejer R, Vach W, Iachine I et al. Heritability of spinal pain and consequences of spinal pain: a comprehensive genetic epidemiologic analysis using a population-based sample of 15,328 twins ages 20-71 years. Arthritis Rheum 2009;61:1343-51.
14. MacGregor AJ, Andrew T, Sambrook PN, Spector TD. Structural, psychological, and genetic influences on low back and neck pain: a study of adult female twins. Arthritis Rheum 2004;51:160-7.
15. Markkula R, Jarvinen P, Leino-Arjas P, Koskenvuo M, Kalso E, Kaprio J. Clustering of symptoms associated with fibromyalgia in a Finnish Twin Cohort. Eur J Pain 2009;13:744-50.
16. Cohen H, Neumann L, Glazer Y, Ebstein RP, Buskila D. The relationship between a common catechol-Omethyltransferase (COMT) polymorphism val (158) met and fibromyalgia. Clin Exp Rheumatol 2009;27(5 Suppl 56):S51-6.
17. McLean SA, Diatchenko L, Lee YM, Swor RA, Domeier RM, Jones JS et al. Catechol O-methyltransferase haplotype predicts immediate musculoskeletal neck pain and psychological symptoms after motor vehicle collision. J Pain 2011;12:101-7.
18. Lee PJ, Delaney P, Keogh J, Sleeman D, Shorten GD. Catecholamine-o-methyltransferase polymorphisms are associated with postoperative pain intensity. Clin J Pain 2011;27:93-101.
19. Finan PH, Zautra AJ, Davis MC, Lemery-Chalfant K, Covault J, Tennen H. COMT moderates the relation of daily maladaptive coping and pain in fibromyalgia. Pain 2011;152:300-7.
20. Kolesnikov Y, Gabovits B, Levin A, Voiko E, Veske A. Combined Catechol-O-Methyltransferase and {micro}-Opioid Receptor Gene Polymorphisms Affect Morphine Postoperative Analgesia and Central Side Effects. Anesth Analg 2010 [Epub ahead of print].
21. Barbosa FR, Matsuda JB, Mazucato M, de Castro França S, Zingaretti SM, da Silva LM et al. Influence of catechol-O-methyltransferase (COMT) gene polymorphisms in pain sensibility of Brazilian fibromialgia patients. Rheumatol Int 2010 [Epub ahead of print].
22. Allegri M, De Gregori M, Niebel T, Minella C, Tinelli C, Govoni S et al. Pharmacogenetics and postoperative pain: a new approach to improve acute pain management. Minerva Anestesiol 2010;76:937-44.
23. Dai F, Belfer I, Schwartz CE, Banco R, Martha JF, Tighioughart H et al. Association of catechol-O-methyltransferase genetic variants with outcome in patients undergoing surgical treatment for lumbar degenerative disc disease. Spine J 2010;10:949-57.
24. Diatchenko L, Slade GD, Nackley AG, Bhalang K, Sigurdsson A, Belfer I et al. Genetic basis for individual variations in pain perception and the development of a chronic pain condition. Hum Mol Genet 2005;14:135-43.
25. Zubieta JK, Heitzeg MM, Smith YR, Bueller JA, Xu K, Xu Y et al. COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor. Science 2003;299:1240-3.
26. Diatchenko L, Nackley AG, Slade GD, Bhalang K, Belfer I, Max MB et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain evoking stimuli. Pain 2006;125:216-24.
27. Sia AT, Lim Y, Lim EC, Goh RW, Law HY, Landau R et al. A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia. Anesthesiology 2008;109:520-6.
28. Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley III JL. Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 2009;10:447-85.
29. Huang CJ, Liu HF, Su NY, Hsu YW, Yang CH, Chen CC et al. Association between human opioid receptor genes polymorphisms and pressure pain sensitivity in females. Anaesthesia 2008;63:1288-95.
30. Lotsch J, Geisslinger G. Relevance of frequent mu-opioid receptor polymorphisms for opioid activity in healthy volunteers. Pharmacogenomics J 2006;6:200-10.
31. Zhang W, Chang YZ, Kan QC, Zhang LR, Lu H, Chu QJ et al. Association of human micro-opioid receptor gene polymorphism A118G with fentanyl analgesia consumption in Chinese gynaecological patients. Anaesthesia 2010;65:130-5.
32. Zhang W, Yuan JJ, Kan QC, Zhang LR, Chang YZ, Wang ZY. Study of the OPRM1 A118G genetic polymorphism associated with postoperative nausea and vomiting induced by fentanyl intravenous analgesia. Minerva Anestesiol 2010 [Epub ahead of print].
33. Reyes-Gibby CC, Shete S, Rakvåg T, Bhat SV, Skorpen F, Bruera E et al. Exploring joint effects of genes and the clinical efficacy of morphine for cancer pain: OPRM1 and COMT gene. Pain 2007;130:25-30.
34. Sweitzer SM, Minella CE, Wilson SP, Raja SN. Peripheral opioid analgesia for the treatment of neuropathic pain: Gene mutation to virus mediated gene transfer. Eur J Pain Suppl 2010;4:251-6.
35. Waxman SG. Polymorphisms in ion channel genes: emerging roles in pain. Brain 2010;133:2515-8.
36. Dib-Hajj SD, Cummins TR, Black JA, Waxman SG. From genes to pain: Nav1.7 and human pain disorders. Trends Neurosci 2007;30:555-63.
37. Nilsen KB, Nicholas AK, Woods CG, Mellgren SI, Nebuchennykh M, Aasly J. Two novel SCN9A mutations causing insensitivity to pain. Pain 2009;143:155-8.
38. Swayne LA, Bourinet E. Voltage-gated calcium channels in chronic pain: emerging role of alternative splicing. Pflugers Arch 2008;456:459-66.
39. Costigan M, Belfer I, Griffin RS, Dai F, Barrett LB, Coppola G et al. Multiple chronic pain states are associated with a common amino acid-changing allele in KCNS1. Brain 2010;133:519-27.
40. Zheng M, Peltz G. Genetic discovery: the prescription for chronic pain. Genome Med 2010;2:82.
41. Jannetto PJ, Bratanow NC. Pharmacogenomic considerations in the opioid management of pain. Genome Med 2010;15:66.
42. Zhou SF. Polymorphism of human cytochrome P450 2D6 and its clinical significance: Part I. Clin Pharmacokinet 2009;48:689-723.
43. Werner MU, Kehlet H. Characterization of persistent postoperative pain by quantitative sensory testing. Eur J Pain Suppl 2010;4:203-7.
44. Granot M. Can we predict persistent postoperative pain by testing preoperative experimental pain?. Curr Opin Anaesthesiol 2009;22:425-30.
45. Arendt-Nielsen L, Yarnitsky D. Experimental and clinical applications of quantitative sensory testing applied to skin, muscles and viscera. J Pain 2009;10:556-72.
46. Aasvang EK, Gmaehle E, Hansen JB, Gmaehle B, Forman JL, Schwarz J et al. Predictive risk factors for persistent postherniotomy pain. Anesthesiology 2010;112:957-69.
47. Werner MU, Mjobo HN, Nielsen PR, Rudin A. Prediction of postoperative pain: a systematic review of predictive experimental pain studies. Anesthesiology 2010;112:1494-502.
48. Rudin A, Eriksson L, Liedholm R, List T, Werner MU. Prediction of postoperative pain after mandibular third molar surgery. J Orofac Pain 2010;24:189-96.
49. Pan PH, Coghill R, Houle TT, Seid MH, Lindel WM, Parker RL et al. Multifactorial preoperative predictors for postcesarean section pain and analgesic requirement. Anesthesiology 2006;104:417-25.
50. Raja SN, Jensen TS. Predicting postoperative pain based on preoperative pain perception: are we doing better than the weatherman? Anesthesiology 2010;112:1311-2.
51. Aasvang EK, Brandsborg B, Jensen TS, Kehlet H. Heterogeneous sensory processing in persistent postherniotomy pain. Pain 2010;150:237-42.
52. Simon MJG, Veering BT. Factors affecting the pharmacokinetics and neural block characteristics after epidural administration of local anaesthetics. Eur J Pain Suppl 2010;4:209-18.
53. De Andrés J, Reina MA, Prats A. Epidural space and regional anesthesia. Eur J Pain Suppl 2009;3:55-64.
54. Reina MA, Franco CD, López A, Dé Andrés JA, van Zundert A. Clinical implications of epidural fat in the spinal canal. A scanning electron microscopic study. Acta Anaesth Belg 2009;60:7-17.
55. Burm AGL. Clinical pharmacokinetics of epidural and spinal anaesthesia. Clin Pharmacokinet 1989;16:283-311.
56. Simon MJ, Veering BT, Stienstra R, van Kleef JW, Williams SG, McGuire GM et al. The systemic absorption and disposition of levobupivacaine 0.5% after epidural administration in surgical patients: a stable-isotope study. Eur J Anaesthesiol 2004;21:460-70.
57. Simon MJG, Veering BT, Stienstra R, van Kleef JW, Burm AGL. Effect of age on the clinical profile and systemic absorption and disposition of levobupivacaine after epidural administration. Br J Anaesth 2004;93:512-2.
58. Simon MJG, Veering BT, Vletter AA, Stienstra R, van Kleef JW, Burm AGL. The effect of age on the systemic absorption and systemic disposition of ropivacaine after epidural administration. Anesth Analg 2006;102:276-82.
59. Allegri M, Niebel T, Baldi C, Bettinelli S, Cusato M, Braschi A, Regazzi M. Plasma concentrations of levobupivacaine increase under continuous infusion after a major surgery. Acta Anaesthesiol Scand 2010;54:654-5.
60. Cusato M, Allegri M, Niebel T, Ingelmo P, Broglia M, Braschi A, Regazzi M. Flip-flop kinetics of ropivacaine during continuous epidural infusion influences its accumulation rate. Eur J Clin Pharmacol 2011;67:399-406
61. Bromage PR. Mechanism of action of extradural analgesia. Br J Anaesth 1975;47:199-211.
62. Igarashi T, Hirabayashi Y, Shimizu R, Saitoh K, Fukuda H, Mitsuhata H. The lumbar extradural structure changes with increasing age. Br J Anaesth 1997;78:149-52.
63. Olofsen E, Burm AGL, Simon MJ, Veering BT, van Kleef JW, Dahan A. Population pharmacokinetic-pharmacodynamic modeling of epidural anesthesia. Anesthesiology 2008;109:664-74.
64. White P, Kehlet H. Improving Postoperative Pain Management: What Are the Unresolved Issues? Anesthesiology 2010;112:220-5.
65. Allegri M, Delazzo MG, Grossi P, Borghi B. Efficacy of drugs in regional anesthesia: a review. Eur J Pain Suppl 2009;3:41-8.
66. Savoia G, Alampi D, Amantea B, Ambrosio F, Arcioni R, Berti M et al. Postoperative pain treatment SIAARTI Recommendations 2010. Short version. Minerva Anestesiol 2010;76:657-67.
67. SFAR Committees on Pain and Local Regional Anaesthesia and on Standards. Expert panel guidelines (2008). Postoperative pain management in adults and children. SFAR committees on pain and local regional anaesthesia and on standards. Ann Fr Anesth Reanim 2009;28:403-9.
68. Coluzzi F, Savoia G, Paoletti F, Costantini A, Mattia C. Postoperative pain survey in Italy (POPSI): a snapshot of current national practices. Minerva Anestesiol 2009;75:622-31.
69. Allegri M. Postoperative pain in Italy: an update. Minerva Anestesiol 2009;75:604-6.
70. Allegri M, Niebel T, Bugada D, Coluzzi F, Baciarello M, Berti M et al. RICALOR Group Investigators. Regional analgesia in Italy: A survey of current practice. Eur J Pain Suppl 2010;4:219-25.
71. Benhamou D, Berti M, Brodner G, De Andres J, Draisci G, Moreno-Azcoita M et al. Postoperative Analgesic Therapy Observational Survey (PATHOS): a practice pattern study in seven central/southern European countries. Pain 2008;136:134-41.
72. Horlocker TT. Complications of regional anesthesia. Eur J Pain Suppl 2010;4:227-34.
73. Mariano E. Continuous peripheral nerve blocks in acute pain management. Eur J Pain Suppl 2010;4:239-44.
74. Ingelmo PM, Somaini M, Bucciero M, Allegri M, Bugada D, Cusato M et al. Nebulization of local anaesthetics in laparoscopic surgery: A new tool for postoperative analgesia Eur J Pain Suppl 2010;4:235-8.
75. Liu SS, Richman JM, Thirlby RC, Wu CL. Efficacy of Continuous Wound Catheters Delivering Local Anesthetic for Postoperative Analgesia: A Quantitative and Qualitative Systematic Review of Randomized Controlled Trials. J Am Coll Surg 2006;203:914-31.
76. Moen V, Dahlgren N, Irestedt L. Severe neurological complications after central neuraxial blockades in Sweden 1990-1999. Anesthesiology 2004;101:950-9.
77. Myers RR, Heckman HM. Effects of local anesthesia on nerve blood flow: studies using lidocaine with and without epinephrine. Anesthesiology 1989;71:757-62.
78. Rigler ML, Drasner K, Krejcie TC, Yelich SJ, Scholnick FT, DeFontes J, Bohner D. Cauda equina syndrome after continuous spinal anesthesia. Anesth Analg 1991;72:275-81.
79. Auroy Y, Benhamou D, Bargues L, Ecoffey C, Falissard B, Mercier FJ et al. Major complications of regional anesthesia in France: the SOS regional anesthesia hotline service. Anesthesiology 2002;97:1274-80.
80. Horlocker TT, McGregor DG, Matsushige DK, Schroeder DR, Besse JA. A retrospective review of 4767 consecutive spinal anesthetics: central nervous system complications. Anesth Analg 1997;84:578-84.
81. Motamed C, Bouaziz H, Mercier FJ, Benhamou D. Knotting of a femoral catheter. Reg Anesth 1997;22:486-7.
82. Capdevila X, Pirat P, Bringuier S, Gaertner E, Singelyn F, Bernard N et al. Continuous peripheral nerve blocks in hospital wards after orthopedic surgery: a multicenter prospective analysis of the quality of postoperative analgesia and complications in 1416 patients. Anesthesiology 2005;103:1035-45.
83. Breivik H, Bang U, Jalonen J, Vigfusson G, Alahuhta S, Lagerkranser M. Nordic guidelines for neuraxial blocks in disturbed haemostasis from the Scandinavian Society of Anaesthesiology and Intensive Care Medicine. Acta Anaesthesiol Scand 2010;54:16-41.
84. Horlocker TT, Wedel DJ, Rowlingson JC, Kayser Enneking F, Kopp SL, Benzon HT. Regional anesthesia in the patient receiving antithrombotic or thrombolytic therapy. Reg Anesth Pain Med 2010;35:64-101.
85. Drasner K. Local anesthetic neurotoxicity: clinical injury and strategies that may minimize risk. Reg Anesth Pain Med 2002;27:576-80.
86. Neal M, Bernards CM, Buterworth JF, Di Gregorio G, Drasner K, Hejtmanek MR et al. ASRA Practice Advisory on Local Anesthetic Systemic Toxicity. Reg Anesth Pain Med 2010;35:152-61.
87. Grossi P, Barbaglio C, Violini A, Allegri M, Niebel T. Regional anesthesia update. Minerva Anestesiol 2009;75:622-31.
88. Grant SA, Nielsen KC, Greengrass RA, Steele SM, Klein SM. Continuous peripheral nerve block for ambulatory surgery. Reg Anesth Pain Med 2001;26:209-14.
89. Grossi P, Allegri M. Continuous peripheral nerve blocks: state of the art. Curr Opin Anaesthesiol 2005;18:522-6.
90. Mariano ER. Making it work: setting up a regional anesthesia program that provides value. Anesthesiol Clin 2008;26:681-92.
91. Salinas FV, Neal JM, Sueda LA, Kopacz DJ, Liu SS. Prospective comparison of continuous femoral nerve block with nonstimulating catheter placement versus stimulating catheter-guided perineural placement in volunteers. Reg Anesth Pain Med 2004;29:212-20.
92. Fredrickson MJ, Ball CM, Dalgleish AJ. A prospective randomized comparison of ultrasound guidance versus neurostimulation for interscalene catheter placement. Reg Anesth Pain Med 2009;34:590-4.
93. Mariano ER, Cheng GS, Choy LP, Loland VJ, Bellars RH, Sandhu NS et al. Electrical stimulation versus ultrasound guidance for popliteal-sciatic perineural catheter insertion: a randomized controlled trial. Reg Anesth Pain Med 2009;34:480-5.
94. Urmey WF. Electrical stimulation and ultrasound in regional anesthesia. Eur J Pain Suppl 2010;4:319-22.
95. Ilfeld BM, Enneking FK. Continuous peripheral nerve blocks at home: a review. Anesth Analg 2005;100:1822-33.
96. Borghi B, Bugamelli S, Stagni G, Missiroli M, Genco R, Colizza MT. Perineural infusion of 0.5% ropivacaine for successful treatment of phantom limb syndrome: a case report. Minerva Anestesiol 2009;75:661-4.
97. Borghi B, D'Addabbo M, White PF, Gallerani P, Toccaceli L, Raffaeli W et al. The use of prolonged peripheral neural blockade after lower extremity amputation: the effect on symptoms associated with phantom limb syndrome. Anesth Analg 2010;111:1308-15.
98. Cervero F, Laird JM. Visceral pain. Lancet 1999;353:2145-8.
99. Gupta A. Local anaesthesia for pain relief after laparoscopic cholecystectomy-a systematic review. Best Pract Res Anaesthesiol 2005;19:275-92.
100. Alkhamesi NA, Peck DH, Lomax D, Darzi AW. Intraperitoneal aerolization of bupivacaine reduces postoperative pain in laparoscopic surgery: a randomized prospective controlled double-blinded clinical trial. Surg Endosc 2007;21:602-6.
101. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain: a review of the evidence. Clin J Pain 2008;24:469-78.
102. Mahowald ML, Singh JA, Majeski P. Opioid use by patients in an orthopedics spine clinic. Arthritis and Rheumatism 2005;52:312-21.
103. Kalso E, Edwards JE, Moore RA, McQuay HJ. Opioids in chronic non-cancer pain: systematic review of efficacy and safety. Pain 2004;112:372-80.
104. Eisenberg E, McNicol ED, Carr DB. Efficacy and safety of opioid agonists in the treatment of neuropathic pain of nonmalignant origin. JAMA 2005;293:3043-52.
105. Varrassi G, Müller-Schwefe G, Pergolizzi J, Orónska A, Morlion B, Mavrocordatos P et al. Pharmacological treatment of chronic pain-the need for CHANGE. Curr Med Res Opin 2010;26:1231-45.
106. Müller-Schwefe G, Jaksch W, Morlion B, Kalso E, Schäfer M, Coluzzi F, Huygen F et al. Make a CHANGE: optimising communication and pain management decisions. Curr Med Res Opin 2011;27:481-8.
107. Breivik H, Collett B, Ventafridda V, Cohen R, Gallacher D. Survey of chronic pain in Europe: prevalence, impact on daily life, and treatment. Eur J Pain 2006;10:287-333.
108. Kress HG. Tapentadol and its two mechanisms of action: is there a new pharmacological class of centrally-acting analgesics on the horizon? Eur J Pain 2010;14:781-3.
109. Mueller-Lissner S. Fixed combination of oxycodone with naloxone: a new way to prevent and treat opioid-induced constipation. Adv Ther 2010;27:581-90.
110. Coluzzi F, Mattia C. OROS® hydromorphone in chronic pain management: when drug delivery technology matches clinical needs. Minerva Anestesiol 2010;76:833-43.
111. Grossman SA, Nesbit S. A subcutaneous polymeric opioid delivery system for the treatment of cancer pain. Eur J Pain Suppl 2010;4:319-322.
112. Ballantyne JC, Mao J. Opioid therapy for chronic pain. New Engl J Med 2003;349:1943-53.
113. Sjøgren P, Olsen AK, Thomsen AB, Dalberg J. Neuropsychological performance in cancer patients: the role of oral opioids, pain and performance status. Pain 2000;86:237-45.
114. Cole BE. Prescribing Opioids, Relieving Patient Suffering and Staying Out of Personal Trouble with Regulators. The Pain Practitioner 2002;12:5-8.
115. Gourlay DL, Heit HA, Almahrezi A. Universal Precautions in Pain Medicine: A Rational Approach to the Treatment of Chronic Pain. Pain Medicine 2005;6:107-12.
116. Von Korff M, Merrill JO, Rutter CM, Sullivan M, Campbell CI et al. Time-scheduled vs. pain-contingent opioid dosing in chronic opioid therapy. Pain 2011;152:1256-62.
117. Ballantyne JC. Opioids around the clock? Pain 2011;152:1221-2.
118. De Gregori M, De Gregori S, Ranzani GN, Allegri M, Govoni S, Regazzi M. Individualizing pain therapy with opioids: The rational approach based on pharmacogenetics and pharmacokinetics. Eur J Pain Suppl 2010;4:245-50.
119. Wasan AD, Wootton J, Jamison RN. Dealing with difficult patients in your pain practice. Reg Anesth Pain Med 2005;30:184-92.
120. Clark MR, Galati S. Opioids and psychological issues: A practical, patient-centered approach to a risk evaluation and mitigation strategy. Eur J Pain Suppl 2010;4:245-50.
121. Ruan X. Sustained-release morphine sulfate with sequestered naltrexone for moderate to severe pain: a new opioid analgesic formulation and beyond. Expert Opin Pharmacother 2011;12:999-1001.
122. Schneider JP, Matthews M, Jamison RN. Abuse-deterrent and tamper-resistant opioid formulations: what is their role in addressing prescription opioid abuse? CNS Drugs 2010;24:805-10.
123. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: A World Health Organization Study in Primary Care. JAMA 1998;280:147-51.
124. Elliott AM, Smith BH, Hannaford PC, Smith WC, Chambers WA. The course of chronic pain in the community: Results of a 4-year follow-up study. Pain 2002;99:299-307.
125. Luo X, Pietrobon R, Sun SX, Liu GG, Hey L. Estimates and patterns of direct health care expenditures among individuals with back pain in the United States. Spine 2004;29:79-86.
126. Ricci JA, Stewart WF, Chee E, Leotta C, Foley K, Hochberg MC. Back pain exacerbations and lost productive time costs in United States workers. Spine 2006;31:3052-60.
127. Van Buyten JP, Linderoth B. "The failed back surgery syndrome": Definition and therapeutic algorithms-An update. Eur J Pain Suppl 2010;4:273-86.
128. Reina MA, De Andres JA, Hernandez JM, Prats-Galino A, Maches F, Pelaez J. Transforaminal or translaminar approach for dorsal root ganglion and dorsal nerve root. Anatomical reason for technique decision. Eur J Pain Suppl 2010;4:287-97.
129. Fager CA, Freidberg SR. Analysis of failures and poor results of lumbar spine surgery. Spine 1980;5:87-94.
130. Spengler DM, Freeman C, Westbrook R, Miller JW. Lowback pain following multiple lumbar spine procedures. Failure of initial selection? Spine 1980;5:356-60.
131. Zucherman J, Schofferman J. Pathology of failed back surgery syndrome. In: White A, editor. Failed back surgery syndrome. Philadelphia, PA: Hanley & Belfus; 1986. p. 1-12.
132. Long DM, Filtzer DL, BenDebba M, Hendler NH. Clinical features of the failed-back syndrome. J Neurosurg 1988;69:61-71.
133. Vaccaro AR, Silber JS. Post-traumatic spinal deformity. Spine 2001;26:S111-8.
134. Ohnmeiss DD, Rashbaum RF. Patient satisfaction with spinal cord stimulation for predominant complaints of chronic, intractable low back pain. Spine J 2001;1:358-63.
135. Fan YF, Chong VF. MRI findings in failed back surgery syndrome. Med J Malaysia 1995;50:76-81.
136. Anderson SR. A rationale for the treatment algorithm of failed back surgery syndrome. Curr Rev Pain 2000;4:395-406.
137. Van Boxem K, Cheng J, Patijn J, van Kleef M, Lataster A, Mekhail N, Van Zundert J. 11. Lumbosacral radicular pain. Pain Pract 2010;10:339-58.
138. Winkelmuller M, Winkelmuller W. Long-term effects of continuous intrathecal opioid treatment in chronic pain of nonmalignant etiology. J Neurosurg 1996;85:458-67.
139. Demartini L, Stocco E, Bonezzi C. Failed Back Surgery Syndrome and intrathecal drugs infusion. Eur J Pain Suppl 2010;4:299-301.
140. Barolat G, Oakly J, Law J. Spinal cord stimulation with a multiple electrode paddel lead is effective in treating intractable low back pain. Neuromodulation 2001;4:59-66.
141. Boswell M et al. Interventional techniques: evidence-based practice guidelines in the management of chronic spinal pain. Pain Physician 2007;10:7-111.
142. Manchikanti L, Boswell MV, Singh V, Benyamin RM, Fellows B, Abdi S et al. Comprehensive Evidence-Based Guidelines for Interventional Techniques in the Manage-ment of Chronic Spinal Pain. Pain Physician 2009;12:699-802.
143. Cramer GD. The thoracic region. In: Cramer GD, Darby SA, editors. Basis and clinical anatomy of the spine, spine cord, and ANS. St. Louis, MO: Mosby; 1995. p. 156-76.
144. Cramer GD. The lumbar region. In: Cramer GD, Darby SA, editors. Basis and clinical anatomy of the spine, spine cord, and ANS. St. Louis, MO: Mosby; 1995. p. 177-221.
145. Rauschning W. Normal and pathological anatomy of the lumbar roots canals. Spine 1987;12:1008-19.
146. Reina MA, Dittmann M, Lopez A, van Zundert A. New perspectives in the microscopic structure of human dura mater in the dorso lumbar region. Reg Anesth 1997;22:161-6.
147. Tracey I. Can neuroimaging studies identify pain endophenotypes in humans? Nat Rev Neurol 2011;7:173-81.